WIM
PRCT icon

Westside Investment Management’s Procept Biorobotics PRCT Stock Holding History

Westside Investment Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.77K Sell
300
-50
-14% -$1.25K ﹤0.01% 1200
2026
Q1 		$8.75K Buy
350
+250
+250% +$7.04K ﹤0.01% 1142
2025
Q4 		$3.15K Buy
+100
New +$3.32K ﹤0.01% 1272
2025
Q3 		– Sell
-50
Closed -$2.88K – 1416
2025
Q2 		$2.88K Hold
50
– – ﹤0.01% 1197
2025
Q1 		$2.91K Buy
+50
New +$3.41K ﹤0.01% 853

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Westside Investment Management's PRCT Position: Q2 2026 in Review

Westside Investment Management reduced its Procept Biorobotics (PRCT) stake by 14% in Q2 2026, selling an estimated $1.25K and leaving 300 shares worth $6.77K. The position accounts for ﹤0.01% of the portfolio, ranked #1200.

Westside Investment Management first reported a position in PRCT in Q1 2025 and has held it in 5 quarters since. The position peaked at $8.75K in Q1 2026. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Westside Investment Management held 300 shares of Procept Biorobotics worth $6.77K as of Q2 2026.
  • Westside Investment Management sold 50 Procept Biorobotics shares in Q2 2026, an estimated $1.25K.
  • Procept Biorobotics made up ﹤0.01% of Westside Investment Management's portfolio in Q2 2026, its #1200 holding.
  • Westside Investment Management first reported a position in Procept Biorobotics in Q1 2025 and has held it in 5 quarters since.
  • Westside Investment Management's Procept Biorobotics position peaked at $8.75K in Q1 2026.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.